Cholestasis of Parenteral Nutrition
7
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
80%
4 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis
Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates
Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis
Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants
Omegaven as Alternative Parenteral Fat Nutrition
Compassionate Use of Omegaven in Children
Safer Parenteral Nutrition in Pediatric Short Bowel Syndrome to Decrease Liver Damage